Mycobacterium ulcerans infections cause progressive muscle atrophy and dysfunction, and mycolactone impairs satellite cell proliferation

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 300, Issue 3, 2011, Pages

  Houngbédji, Germain Mabèrou ^a   Bouchard, Patrice ^b   Frenette, Jérôme ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Degeneration; Edema; Fibrosis; Muscle regeneration; Skeletal muscle force

Indexed keywords

ATROGIN 1; MUSCLE RING FINGER 1 PROTEIN; MYOGENIN; TRANSCRIPTION FACTOR PAX7; UBIQUITIN PROTEIN LIGASE E3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BICEPS BRACHII MUSCLE; BURULI ULCER; C57BL 6 MOUSE; CELL FUNCTION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; HISTOPATHOLOGY; ISOMETRICS; MALE; MOUSE; MYCOBACTERIUM ULCERANS; MYOFIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROGRESSIVE MUSCULAR ATROPHY; PROTEIN EXPRESSION; SATELLITE CELL; SKELETAL MUSCLE; UPREGULATION;

ANIMALS; BACTERIAL TOXINS; BURULI ULCER; CELL PROLIFERATION; CONTRACTURE; DISEASE MODELS, ANIMAL; FIBROSIS; INJECTIONS, INTRAMUSCULAR; ISOMETRIC CONTRACTION; MALE; MICE; MICE, INBRED C57BL; MUSCLE FATIGUE; MUSCLE PROTEINS; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYCOBACTERIUM ULCERANS; MYOD PROTEIN; NECROSIS; PAX7 TRANSCRIPTION FACTOR; SATELLITE CELLS, SKELETAL MUSCLE; SKP CULLIN F-BOX PROTEIN LIGASES; TIME FACTORS; UBIQUITIN-PROTEIN LIGASES;

EID: 79954543335     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00393.2010     Document Type: Article

References (36)

1. Beisel WR. Metabolic effects of infection. Prog Food Nutr Sci 8: 43-75, 1984.
2. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708, 2001.
3. Booth FW, Gollnick PD. Effects of disuse on the structure and function of skeletal muscle. Med Sci Sports Exerc 15: 415-420, 1983.
4. Bischoff R. Analysis of muscle regeneration using single myofibers in culture. Med Sci Sports Exerc 21: S164-S172, 1989.
5. Du J, Wang X, Miereles C, Bailey JL, Debigare R, Zheng B, Price SR, Mitch WE. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest 113: 115-123, 2004.
6. Dumont N, Frenette J. Macrophages protect against muscle atrophy and promote muscle recovery in vivo and in vitro: a mechanism partly dependent on the insulin-like growth factor-1 signaling molecule. Am J Pathol 176: 2228-2235, 2010.
7. Ellen DE, Stienstra Y, Teelken MA, Dijkstra PU, van der Graaf WT, van der Werf TS. Assessment of functional limitations caused by Mycobacterium ulcerans infection: towards a Buruli ulcer functional limitation score. Trop Med Int Health 8: 90-96, 2003.
8. En J, Goto M, Nakanaga K, Higashi M, Ishii N, Saito H, Yonezawa S, Hamada H, Small PL. Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (buruli ulcer) in a murine study. Infect Immun 76: 2002-2007, 2008.
9. Frost RA, Lang CH. Skeletal muscle cytokines: regulation by pathogenassociated molecules and catabolic hormones. Curr Opin Clin Nutr Metab Care 8: 255-263, 2005.
10. George KM, Pascopella L, Welty DM, Small PL. A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect Immun 68: 877-883, 2000.
11. Guarner J, Bartlett J, Whitney EA, Raghunathan PL, Stienstra Y, Asamoa K, Etuaful S, Klutse E, Quarshie E, van der Werf TS, van der Graaf WT, King CH, Ashford DA. Histopathologic features of Mycobacterium ulcerans infection. Emerg Infect Dis 9: 651-656, 2003.
12. Hasselgren PO, Fischer JE. Sepsis: stimulation of energy-dependent protein breakdown resulting in protein loss in skeletal muscle. World J Surg 22: 203-208, 1998.
13. Helliwell TR, Wilkinson A, Griffiths RD, McClelland P, Palmer TE, Bone JM. Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin. Neuropathol Appl Neurobiol 24: 507-517, 1998.
14. Herndon DN, Ramzy PI, DebRoy MA, Zheng M, Ferrando AA, Chinkes DL, Barret JP, Wolfe RR, Wolf SE. Muscle protein catabolism after severe burn: effects of IGF-1/IGFBP-3 treatment. Ann Surg 229: 713-720, 1999.
15. Hong H, Coutanceau E, Leclerc M, Caleechurn L, Leadlay PF, Demangel C. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs. PLoS Negl Trop Dis 2: e325, 2008.
16. Houngbedji GM, Cote CH, Small PL, Frenette J. Limited repair and structural damages displayed by skeletal muscles loaded with mycolactone. Microbes Infect 11: 238-244, 2009.
17. Houngbedji MG, Boissinot M, Bergeron GM, Frenette J. Subcutaneous injection of Mycobacterium ulcerans causes necrosis, chronic inflammatory response and fibrosis in skeletal muscle. Microbes Infect 10: 1236-1243, 2008.
18. Koh TJ, Bryer SC, Pucci AM, Sisson TH. Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration. Am J Physiol Cell Physiol 289: C217-C223, 2005.
19. Kuang S, Charge SB, Seale P, Huh M, Rudnicki MA. Distinct roles for Pax-7 and Pax3 in adult regenerative myogenesis. J Cell Biol 172: 103-113, 2006.
20. Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, Leibovitch SA. Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo. PLoS One 4: e4973, 2009.
21. Langen RC, Schols AM, Kelders MC, van der Velden JL, Wouters EF, Janssen-Heininger YM. Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation. Am J Respir Cell Mol Biol 35: 689-696, 2006.
22. Li H, Malhotra S, Kumar A. Nuclear factor-κ B signaling in skeletal muscle atrophy. J Mol Med 86: 1113-1126, 2008.
23. Lindon C, Montarras D, Pinset C. Cell cycle-regulated expression of the muscle determination factor Myf5 in proliferating myoblasts. J Cell Biol 140: 111-118, 1998.
24. Nicolas N, Gallien CL, Chanoine C. Analysis of MyoD, myogenin, and muscle-specific gene mRNAs in regenerating Xenopus skeletal muscle. Dev Dyn 207: 60-68, 1996.
25. Ouattara D, Meningaud JP, Kaba L, Sica A, Asse H. [Plastic surgery treatment of Buruli ulcer sequelaes. A retrospective study of 16 patients]. Ann Chir Plast Esthet 48: 13-19, 2003.
26. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA. Pax7 is required for the specification of myogenic satellite cells. Cell 102: 777-786, 2000.
27. Shi X, Garry DJ. Muscle stem cells in development, regeneration, and disease. Genes Dev 20: 1692-1708, 2006.
28. Snyder DS, Small PL. Uptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulcerans. Microb Pathog 34: 91-101, 2003.
29. Supinski GS, Vanags J, Callahan LA. Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction. Am J Physiol Lung Cell Mol Physiol 296: L994-L1001, 2009.
30. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev 89: 381-410, 2009.
31. Ventadour S, Attaix D. Mechanisms of skeletal muscle atrophy. Curr Opin Rheumatol 18: 631-635, 2006.
32. 2-activated, and ubiquitin-proteasome proteolytic pathways. J Clin Invest 97: 1610-1617, 1996.
33. Witt SH, Granzier H, Witt CC, Labeit S. MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination. J Mol Biol 350: 713-722, 2005.
34. Wouters EF. Muscle wasting in chronic obstructive pulmonary disease: to bother and to measure! Am J Respir Crit Care Med 173: 4-5, 2006.
35. Wray CJ, Mammen JM, Hershko DD, Hasselgren PO. Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int J Biochem Cell Biol 35: 698-705, 2003.
36. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117: 524-529, 2007.